Prostate Cancer Cohort Consortium · PC3
The Prostate Cancer Cohort Consortium (PC3) is a working group within the National Cancer Institute (NCI) Cohort Consortium.
Mission
The mission of PC3 is to bring together intramural and extramural researchers and resources to address outstanding research questions in prostate cancer etiology, prevention, and survivorship.
Goals
- To provide a forum for researchers with expertise and/or interest in prostate cancer to form large-scale collaborations and coalesce around ideas and methodologic approaches.
- To create shared data and biospecimen resources for pooled studies of prostate cancer, with an emphasis on rarer prostate cancer outcomes (i.e., clinical and molecular disease subtypes) that are difficult to study in a single cohort.
- To fill knowledge gaps in prostate cancer epidemiology, including but not limited to:
- Etiology of clinical and molecular disease subtypes
- Survival and survivorship among men with a prostate cancer diagnosis
- Reasons and mitigation strategies for racial disparities in prostate cancer incidence and mortality
